4D Molecular Therapeutics, Inc 10-Q for FY2022 Q2
4D Molecular Therapeutics, Inc. (FDMT)
10-Q
2022-08-11
For: 2022-06-30
View Original
Added on
April 08, 2026
About this 10-Q
4D Molecular Therapeutics, Inc filed this 10-Q on August 11, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $162K
- down 98.9% from $14.58M a year earlier
- Net loss
- $28.09M
- compared with a net loss of $7.59M a year earlier
- Diluted EPS
- -$0.87
- compared with -$0.28 a year earlier